Literature DB >> 17390173

Larger amounts of nitrite and nitrate-reducing bacteria in megaesophagus of Chagas' disease than in controls.

D Pajecki1, B Zilberstein, I Cecconello, M A A Dos Santos, O K Yagi, J J Gama-Rodrigues.   

Abstract

In the megaesophagus of Chagas' disease, chronic esophagitis is caused by stasis of swallowed food and saliva. In this environment, the overgrowth of aerobic and anaerobic bacteria, including nitrate-reducing bacteria, is observed. The reduction of nitrate into nitrite by the action of these bacteria has been associated with the formation of volatile nitrosamines in different situations of gastric bacterial overgrowth. We have hypothesized that this phenomenon could occur in the esophageal lumen of patients with megaesophagus. To evaluate the concentration of nitrite, the presence of volatile nitrosamines and the concentration of nitrate-reducing bacteria in the esophageal lumen of patients with non-advanced megaesophagus of Chagas' disease and in a group of patients without esophageal disease. Fifteen patients with non-advanced megaesophagus [megaesophagus group (MG)] and 15 patients without any esophageal disease [control group (CG)] were studied. Saliva samples were taken for nitrate and nitrite quantitative determination and esophageal stasis liquid samples were taken for nitrate and nitrite quantitative determination, volatile nitrosamines qualitative determination and reductive bacteria quantitative determination. MG and CG were equivalent in nitrate and nitrite saliva concentration and in nitrate esophageal concentration. Significant difference was found in nitrite (p = 0.003) and reductive bacteria concentration (p < 0.0001), both higher in MG. Volatile nitrosamines were identified in three MG patients and in none of the CG patients, but this was not significant (p = 0.113). There is a higher concentration of reductive bacteria in MG, responsible for the rise in nitrite concentration at the esophageal lumen and, eventually, for the formation of volatile nitrosamines.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17390173     DOI: 10.1007/s11605-006-0066-y

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  18 in total

1.  [Clinical and radiological aspects of aperistalsis of the esophagus].

Authors:  J de REZENDE; K M LAUAR; A de OLIVEIRA
Journal:  Rev Bras Gastroenterol       Date:  1960 Sep-Dec

Review 2.  Risk factors for squamous cell carcinoma of the oesophagus.

Authors:  U Ribeiro; M C Posner; A V Safatle-Ribeiro; J C Reynolds
Journal:  Br J Surg       Date:  1996-09       Impact factor: 6.939

3.  Intragastric volatile N-nitrosamines, nitrite, pH, and Helicobacter pylori during long-term treatment with omeprazole.

Authors:  I T Vermeer; L G Engels; D M Pachen; J W Dallinga; J C Kleinjans; J M van Maanen
Journal:  Gastroenterology       Date:  2001-09       Impact factor: 22.682

4.  Early cancer in achalasia.

Authors:  L F Loviscek; M C Cenoz; A E Badaloni; O Agarinakazato
Journal:  Dis Esophagus       Date:  1998-10       Impact factor: 3.429

5.  Microbial flora of the normal esophagus.

Authors:  D Gagliardi; S Makihara; P R Corsi; A de T Viana; M V Wiczer; S Nakakubo; L M Mimica
Journal:  Dis Esophagus       Date:  1998-10       Impact factor: 3.429

6.  Volatile N-nitrosamines in gastric juice of patients with various conditions of the gastrointestinal tract determined by gas chromatography-mass spectrometry and related to intragastric pH and nitrate and nitrite levels.

Authors:  J W Dallinga; D M Pachen; A H Lousberg; J A van Geel; G M Houben; R W Stockbrügger; J M van Maanen; J C Kleinjans
Journal:  Cancer Lett       Date:  1998-02-27       Impact factor: 8.679

7.  Effect of omeprazole on intragastric bacterial counts, nitrates, nitrites, and N-nitroso compounds.

Authors:  E Verdu; F Viani; D Armstrong; R Fraser; H H Siegrist; B Pignatelli; J P Idström; C Cederberg; A L Blum; M Fried
Journal:  Gut       Date:  1994-04       Impact factor: 23.059

8.  Formation of nitrosamines during consumption of nitrate- and amine-rich foods, and the influence of the use of mouthwashes.

Authors:  J M van Maanen; D M Pachen; J W Dallinga; J C Kleinjans
Journal:  Cancer Detect Prev       Date:  1998

9.  Esophageal carcinoma and achalasia: prevalence, incidence and results of treatment.

Authors:  A Peracchia; A Segalin; R Bardini; A Ruol; L Bonavina; M Baessato
Journal:  Hepatogastroenterology       Date:  1991-12

10.  The risk of esophageal cancer in patients with achalasia. A population-based study.

Authors:  R S Sandler; O Nyrén; A Ekbom; G M Eisen; J Yuen; S Josefsson
Journal:  JAMA       Date:  1995-11-01       Impact factor: 56.272

View more
  4 in total

Review 1.  The noncolonic microbiome: does it really matter?

Authors:  R Daniel Lawson; Walter J Coyle
Journal:  Curr Gastroenterol Rep       Date:  2010-08

Review 2.  The Esophageal Microbiome in Health and Disease.

Authors:  Brooke Corning; Andrew P Copland; Jeanetta W Frye
Journal:  Curr Gastroenterol Rep       Date:  2018-08-01

3.  Four cancer cases after esophageal atresia repair: Time to start screening the upper gastrointestinal tract.

Authors:  Floor Wt Vergouwe; Madeleine Gottrand; Bas Pl Wijnhoven; Hanneke IJsselstijn; Guillaume Piessen; Marco J Bruno; René Mh Wijnen; Manon Cw Spaander
Journal:  World J Gastroenterol       Date:  2018-03-07       Impact factor: 5.742

Review 4.  The Mechanisms for the Association of Cancer and Esophageal Dysmotility Disorders.

Authors:  Francisco Tustumi; Jorge Henrique Bento de Sousa; Nicolas Medeiros Dornelas; Guilherme Maganha Rosa; Milton Steinman; Edno Tales Bianchi
Journal:  Med Sci (Basel)       Date:  2021-05-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.